Latest news, reports, and more from the RedChip Nation.
 
 
 >
Catasys (NASDAQ: CATS) Moves to Rapid Growth Stage
 
 

A new Seeking Alpha report on Catasys (NASDAQ: CATS) makes a clear case for why the company is a gamechanger at the apex where value-based reimbursement and evidence-based treatment models converge to disrupt the Behavioral Health industry.

 

The report notes FY 2019 revenues are forecast to rise over 130% YOY as CATS enters the hyper-growth stage with its healthcare cost-shrinking model (versus the traditional cost-growing income model).

 

CATS provides an evidence-based scalable solution that integrates sophisticated cognitive learning technologies with personalized human engagement to deliver outcomes. In a nutshell, CATS contracts with health insurance carriers to reduce medical costs for “treatment-avoidant” members and collects a percentage of the cost-savings as revenue. In essence, this is the anti-treatment center model, where efficiency and accountability drive revenue growth, a cost-shrinking income model.

 

read full article: seekingalpha.com/article/4265181-catasys-transforming-behavioral-health-blooming-rapid-growth-stage

 

Disclosure

Catasys (NASDAQ: CATS) is a client of RedChip Companies, Inc. CATS agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.

 
 
 
 >
Digital Ally (NASDAQ: DGLY) Reports Q1 2019 Revenue of $2.5 Million; Service- based Revenues Increased 31% from Prior Year
 
 

Digital Ally (NASDAQ: DGLY), which develops, manufactures, and markets advanced video surveillance products for law enforcement, homeland security, and commercial applications, announced its operating results for the first quarter of 2019.

 

• Revenues increased in first quarter 2019 to $2,550,796 from $2,378,287 in fourth quarter 2018 and $2,471,513 in first quarter 2018. The primary reason for the revenue increases in the first quarter 2019 is that DGLY’s service revenues continued to improve.

 

• DGLY has asserted two significant patent infringement lawsuits involving Axon and WatchGuard that have had significant impacts on its quarterly results primarily due to the timing and amount of legal fees expended on such lawsuits. The WatchGuard lawsuit has been settled, as noted below, while the Axon lawsuit remains active.

 

• WatchGuard will pay DGLY a one-time, lump sum settlement payment of six (6) million dollars.

 

Key Quote: “We are encouraged that our service- based revenues increased 31% from the prior year and continued our trend of growth in this area. We are also very pleased that we have settled our lawsuit with WatchGuard. The settlement should serve notice to the industry that we are the rightful owner of ‘auto-activation’ patents and that we intend to defend our patents and to hold infringing parties responsible for their actions.” Stanton E. Ross, Chief Executive Officer of Digital Ally

 

The Backstory: Digital Ally, headquartered in Lenexa, Kansas, specializes in the design and manufacture of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.

 

Disclosure

Digital Ally, Inc. (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.

 

 
 
 
 >
MYnd Analytics (NASDAQ: MYND) Provides Business and Merger Updates
 
 

MYnd Analytics (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, provided a business update and reported significant progress on its planned merger with Emmaus Life Sciences, Inc.

 

Emmaus Merger Update: MYnd shareholders as of the record date, anticipated to be set in the end of June prior to the completion of the merger, are expected to continue to own their allocable portion of 5.9% of Emmaus after the completion of the merger, as set forth in the merger agreement, as well as their allocable portion of the existing predictive analytics and telemedicine business that will be spun off into the newly formed public Delaware corporation, Telemynd, which is expected to begin trading as a new standalone company.

 

PEER Online® Update: The paid pilot program for the Company’s predictive analytics decision support tool to help physicians reduce trial and error treatment for behavioral health conditions, the Psychiatric EEG Evaluation Registry (PEER), with Horizon New Jersey and Hackensack Meridian Health, continues to increase enrollment, and providers using the tool have responded favorably. The Company is also continuing trial enrollment with the Canadian Armed Forces and University of Ottawa.

 

The Backstory: MYnd Analytics (NASDAQ: MYND), with its wholly owned subsidiary Arcadian Telepsychiatry Services LLC, is a technology-enabled telepsychiatry and teletherapy company that provides enhanced access to behavioral health services, improves patient outcomes and helps lower the costs associated with behavioral health issues. The MYnd Psychiatric EEG Evaluation Registry (PEER) is a predictive analytics decision support tool that helps physicians reduce trial and error treatment for behavioral health conditions. PEER provides the physician a personalized care plan with recommended treatment options based on a patient’s unique brain markers, reducing treatment time and treatment costs. Arcadian Telepsychiatry Services LLC provides a suite of complementary telemedicine services that can be combined with PEER, including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. MYnd’s customers include major health plans, health systems, and community-based organizations. To read more about the benefits of this patented technology for patients, physicians and payers, please visit: www.myndanalytics.com.

 

Disclosure

MYnd Analytics, (NASDAQ: MYND) is a client of RedChip Companies, Inc. MYND agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services.

 
 
 
 >
cbdMD (NYSE American: YCBD) Reported Record Q2 Sales and Is Well Ahead of Pace to Achieve Its 2019 Revenue Target
 
 

cbdMD (NYSE American: YCBD) reported last week that in its fiscal quarter ended March 31, 2019, it generated total net sales of $5.7 million, up 84% over prior year results and sales for cbdMD products have grown 55% sequentially from the December 2018 quarter to March 2019 quarter.

 

Why It Matters: YCBD’s March quarter results put the company on pace to meet or exceed the established revenue earn-out targets for its first year of operations for cbdMD, which was $20 million for calendar 2019. In fact, the March quarter was 78% ahead of those earn-out projections. Furthermore, the company is currently trending a full year ahead of the revenue earn-out projections.

 

Key Quote: “Our goal is to build cbdMD into the most recognized cbd brand in the America. Our strong second quarter results place us in a great position to accomplish this goal.” – Martin A. Sumichrast, Chairman and CEO

 

Disclosure

cbdMD (NYSE American: YCBD) is a client of RedChip Companies. YCBD agreed to pay RedChip a monthly cash fee of between $5,000 and $15,000, and 5,000 shares of Rule 144 stock for RedChip investor awareness services. Additionally, the CEO of RedChip Companies owns 13,500 shares of YCBD.

 
 
 
 >
GSRX Industries (OTCQB: GSRX) Reported Record Q1 Revenue of $2.8 Million
 
 

GSRX Industries (OTCQB: GSRX) reported revenue of $2.8 million for the quarter ended March 31, up 73% from the December 31 quarter. Gross profit jumped 102% to $1.5 million in the same period.

 

Why It Matters: GSRX has reached a nearly $12 million annual revenue run rate in just its first year of operations. With more dispensaries slated to open in the near-term and expanding operations in CBD and other areas of cannabis production, GSRX could become one of the big long-term winners in this rapidly evolving space.

 

Key Quote: “We are pleased to report an outstanding performance for the most recent quarter of operations. We continue to meet our operations goals, exceed revenue expectations and judiciously expand our operations. We are looking forward to continued growth throughout 2019.” – Les Ball, CEO

 

Disclosure

GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.

 
 
 
 >
eSports Entertainment (OTCQB: GMBL) Appoints Former Activision Blizzard Executive as CIO
 
 

eSports Entertainment Group (OTCQB: GMBL), a licensed online gambling company with a specific focus on esports wagering and 18+ gaming, announced the appointment of John Brackens as Chief Information Officer, last week. Brackens is a senior level executive with extensive experience in startups, high-tech companies and the gaming industry, holding positions that have included CIO, COO and CTO.

 

The Backstory: During his time at Activision Blizzard, Brackens served as Manager of Network Operations, where he directed IT service management and hardware support for 4,500+ servers and 50+ million monthly active players. In addition to reducing server maintenance costs by 35%, he also improved system uptime to 99.99%. Moreover, he managed technology projects including the automated detection and repair of online services and infrastructure using artificial intelligence. Other key achievements include the creation, execution, and monetization of the League of Gods Asia eSports series, as well as, managing a licensing application for Malta Gaming Authority and Curacao eGaming License.

 

Key Quote: “We are very pleased with the addition of John to our senior management team. His experience at the highest levels of information technology and network operations, especially within different licensing regimes, will be invaluable as the Company embarks on its aggressive growth plans within the global esports industry.” – Grant Johnson, CEO

 

Disclosure

Esports Entertainment Group, Inc. (GMBL) is a client of RedChip Companies, Inc. GMBL agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.

 
 
 
 >
Emerald Health Therapeutics (OTCQX: EMHTF) JV Receives License for 1.1M Sq. Ft. Greenhouse
 
 

Emerald Health Therapeutics (OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received a Standard Processing License (the “Processing License”) from Health Canada for its 1.1 million square foot Delta 3 greenhouse facility.

 

Why It Matters: The Processing License permits Pure Sunfarms to extract and process cannabis at its Delta 3 facility, which will enable the development and manufacture of products derived from cannabis, including oils, other concentrates, and edibles. Pure Sunfarms will require an additional amendment to its sales license to sell cannabis oil, which it expects to be distributing to provincial/territorial distributors and private retailers by the fourth quarter of this year.

 

Key Quote: “Pure Sunfarms has hit its inflection point for significant sales growth. As it continues to build on its critical mass of infrastructure and licensure, and achieves vertical integration, we believe it will increasingly be producing and selling value-added products with higher margins.” – Dr. Avtar Dhillon, President and Executive Chairman

 

 
 
 
 >
Advantego Corporation (OTCQB: ADGO) and InnerScope Hearing Technologies Expand Partnership Agreement
 

 

Advantego Corporation (OTCQB: ADGO) and InnerScope plan to distribute headphones and other assistive listening devices with personalized hearing profiles for the hearing impaired through InnerScope’s vendor agreements with Walmart.com, Sears.com and Kmart.com

 

The Agreement includes a joint development of a proprietary hearing software for self-administered frequency threshold hearing assessment to accurately create personalized hearing profiles based on each person’s hearing strengths and weaknesses. Advantego will be able to offer this proprietary hearing profile software within its range of hardware products to assist the millions of hearing-impaired individuals.

 

The Backstory: Advantego Corporation is a business solutions provider that develops stand-alone digital delivery systems, electronic and enterprise software products to capitalize on niche opportunities within a specific market. The Company leverages a proprietary Intelligent Solution Platform, combining leading third-party, cutting-edge technologies with existing data and systems to deliver a turnkey specialized Business Process as a Service (BPaaS) that is both scalable and cost-effective. The Company offers a variety of stand-alone products and services tailored specifically to targeted industries, combining these with multiple software applications for large enterprises, affiliate networks and franchise operators as comprehensive, managed bundled solutions. The Company’s services also include product design, engineering and OEM manufacturing of hardware products. In addition, it licenses and distributes third-party proprietary software and hardware from a host of Strategic Partners. Website: www.advantego.com. Twitter: @Advantego1.

 

Disclosure

Advantego Corporation (OTCQB: ADGO) is a client of RedChip Companies. Advantego Corporation (OTCQB: ADGO) pays RedChip a monthly cash fee for investor awareness services.

 

 
 
 
 >
RedChip to Hold Group Call Thursday, May 23, with Santa Fe Gold (OTC: SFEG)
 
 

Brian J. Adair, Chairman of the Board of Santa Fe Gold Corp (OTC: SFEG), a U.S.-based mining and exploration enterprise with 148 mining claims comprising 42 potential mines, of which the Jim Crow Gold and Silver Mine is already in production, will hold a group call Thursday, May 23, 2019 at 4 pm Eastern/1 pm Pacific. Duration: 20 minutes.

 

In the call, which will not be archived, Mr. Adair will discuss recent developments and key upcoming milestones. To join the call, which is completely free of charge, please phone RedChip Specialist Craig Brelsford at (407) 571-0902. Craig will give you the number to the conference line and the password.

 

About Santa Fe Gold Corp (OTC: SFEG)

 

Market cap: $25 million

 

U.S.-based mining, management, and exploration enterprise with emphasis on gold, silver, and copper and precious, industrial, and base metals. Owner of multiple claims

 

Operates portfolio of properties in New Mexico, with the five-silver-mine Blackhawk Alhambra complex very likely to become significant silver-play and the Billali 11-mine complex a major gold and silver play

 

Exploration and Development Team is building value of SFEG's portfolio through ongoing exploration and surveillance, analysis, and research with acquisition of multiple grade additional properties and it is finalizing acquisition of several additional attractive and economically viable near-term revenue prospects

 

SFEG's ultimate goal is to operate a portfolio of 12 near-term producing properties as well as several major longer-term potential multi-million-ounce properties currently under negotiation. SFEG expects to complete its remaining acquisitions phase by year end

 

More information: www.santafegoldcorp.com, www.sfeginfo.com

 

Disclosure

Santa Fe Gold Corp. (OTC: SFEG) is a client of RedChip Companies, Inc. SFEG agreed to pay RedChip Companies, Inc. 1,000,000 shares of Rule 144 stock for 12 months of RedChip investor awareness services and consulting services.

 

 
 
 
 
Quote of the Week
 
"There are a lot of risky companies built on one or two products, be wary of those."
- Dave Maley, Manager Ariel Discovery Fund
 
 
 
Lesson of the Week
 
Learn about "beta" in this week's lesson.
Read More
 
 
 
 
Latest Videos
 
 
 
 
3 Small-Caps Positioned for Upside
 
Watch exclusive interviews with executives from top small-cap companies on this week's RedChip Money Report, featuring interview with Genetic Technologies (NASDAQ: GENE), Piedmont Lithium (NASDAQ: PLL), and MYnd Analytics (NASDAQ: MYND).
 
Watch Now
 
 
 
 
ChineseInvestors.com (OTCQB: CIIX) - Targeting Chinese Consumers and Investors in North America
 
ChineseInvestors.com is a fast-growing company targeting Chinese consumers and investors in North America. CIIX provides financial commentary to Chinese Americans with the latest news on the U.S. equity and cryptocurrency markets. CIIX is one of the first Chinese American public companies focused on selling CBD products on ChineseCBDoil.com
 
Watch Now
 
 
 
 
Genetic Technologies (NASDAQ: GENE): New Risk Tests for Breast and Colorectal Cancers
 
Learn about Genetic Technologies (NASDAQ: GENE) innovative, first-in-their-class genetic risk tests for breast and colorectal cancers in this exclusive interview with Chairman & CEO Paul Kasian.
 
Watch Now
 
 
 
 
Green Organic Dutchman: Rapidly Growing Operations Globally
 
Learn about The Green Organic Dutchman (OTCQB: TGODF), a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, in this exclusive interview with Brian Athaide, CEO.
 
Watch Now
 
 
 
 
Piedmont Lithium (NASDAQ: PLL): Only Conventional US Lithium Development Project
 
Exclusive interview with Keith Phillips, President & CEO of Piedmont Lithium (NASDAQ: PLL). Learn about PLL's domestic lithium project, including the multiple near-term catalysts that could drive shares higher.
 
Watch Now
 
 
 
 
Genetic Technologies (NASDAQ: GENE): World-Leading Genetic Tests for Cancer and Other Diseases
 
World-class genetic risk assessment tools for cancers and other diseases position Genetic Technologies for big upside.
 
Watch Now
 
 
 
 
Emerald Health (OTCQX: EMHTF): Growing Operations in Multi-Billion-Dollar Markets Globally
 
Exclusive interview with Rob Hill, CEO of Emerald Health (OTCQX: EMHTF), a Canadian licensed producer of cannabis with large-scale grow, extraction, and production capacity.
 
Watch Now
 
 
 
 
MYnd Analytics (NASDAQ: MYND): Game-Changing AI & Telemedicine Solution for $130B Behavioral Health Market
 
Game-changing big data tech combined with telemedicine and the upside of an FDA-approved drug.
 
Watch Now
 
 
 
 
Rapidly Growing Green Stock in a Multi-Billion-Dollar Market
 
Exclusive interview with GSRX Industries' Chairman Christian Briggs, who discusses the company's rapid growth in the markets for legal medical/recreational marijuana and CBD.
 
Watch Now
 
 
 
 
Sharps Provensa: New Smart Safety Syringe from Sharps Technology
 
Sharps Technology is an innovative medical device company, introducing a portfolio of new safety syringes and safety products with a patented single-use mechanism. This game-changing sheath technology is designed to eliminate infectious needlestick injuries.
 
Watch Now
 
 
 
 
Marker Therapeutics (NASDAQ: MRKR): Next Major Leap in T Cell-Based Immunotherapies for Cancer
 
Exclusive interview with Marker Therapeutics’ (NASDAQ: MRKR) Chief Development Officer Dr. Juan Vera. MRKR is in multiple active Phase 2 clinical trials in the $100+ billion market for immunotherapy cancer drugs. MRKR’s Multi-Antigen Targeted Cell Therapy Platform and Peptide Vaccine Portfolio has the potential to disrupt the CAR-T and TCR filed therapies.
 
Watch Now
 
 
 
 
Electra Meccanica: Sales Growing for Innovative 1- and 2-Seat Electric Vehicles
 
Exclusive interview with Electra Meccanica Vehicles’ (NASDAQ: SOLO) Founder & CEO Jerry Kroll. Drawing on a 59-year history of designing, building and delivering high end specialty cars, SOLO has designed and built the innovative, all electric SOLO, single-seater electric vehicle. The Company began delivering electric vehicles in 2018 and booked in excess of 60,000 pre-orders. The Company expects to deliver $77M worth of cars in 2019.
 
Watch Now
 
 
 
 
Tenax Therapeutics (NASDAQ: TENX): Near-Term Phase 2 Results Expected to Drive Stock
 
Exclusive interview with Tenax Therapeutics (NASDAQ: TENX) CEO Anthony Ditonno.TENX is expected to report Phase 2 results for its pulmonary hypertension treatment by year end. Its innovative treatment is based on an established compound, approved in 60+ countries and cited in 1000+ publications, which provides a strong foundation that de-risks the development opportunity.
 
Watch Now
 
 
 
 
Polar Power: Innovative Power Solutions for Critical Applications
 
Exclusive interview with Polar Power (NASDAQ: POLA) CEO Arthur Sams. POLA is expected to report record revenue for Q4 2018, driven by increased production capacity and service infrastructure. Revenue growth is expected to accelerate in 2019.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Over a 50-year investment horizon, you can expect about 14 bear markets.
Read More
 
 
Weekly Index Performance
 
Large cap indexes rallied moderately last week, while small-cap indexes continued their retreat.
Read More
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
If you received this email by mistake you can
unsubscribe from all emails.